T1	Participants 77 122	maintenance phase of renal anaemia treatment.
T3	Participants 562 646	Eligible patients were 18-75 years old with CKD stage 5 maintained on haemodialysis.
T2	Participants 284 367	patients with anaemia and chronic kidney disease (CKD) maintained on haemodialysis.
T4	Participants 1097 1125	313 patients were randomized
T5	Participants 2235 2262	patients with renal anaemia
